The Pfizer and Chiesi-backed gene therapy developer plans to use the IPO proceeds to advance treatments for Fabry disease, cystic fibrosis and ophthalmological diseases.

Meghan Sharp, number two on this year's GCV Rising Stars list, is taking the COO role at Beyond Limits, leaving investor BP Ventures to do so.

The voice-focused electronic component maker increased its overall funding to more than $90m, raising $19m in equity and debt financing.

Brazen Technologies, which recently secured $3.2m in debt and equity financing, has been backed by existing investor Randstad Innovation Fund.

The savings assistance app developer boosted its overall funding to more than $63m in a $27.5m round featuring Citi Ventures and existing backer GV.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

With news that We Co has withdrawn its IPO filing, we take a look at what the move could mean for corporate venturing going forward.

University of Wisconsin-Madison has become a limited partner in a $75m healthcare fund launched by Venture Investors.

Harvard's genomic editing technology spinout has filed to raise up to $100m, adding to some $225m of venture funding in under three years.

The GV-backed genomic editing technology developer has filed to raise up to $100m, adding to some $225m of venture funding in under three years.